title: A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease.
abstract: Allogeneic bone marrow transplantation is an effective treatment for a number of malignant and nonmalignant diseases (Applebaum. 2001. Nature. 411: 385-389 and Copelan. 2006. N Engl J Med. 354: 1813-1826). However, the application of this therapeutic modality has been impeded by a number of confounding side effects, the most frequent and severe of which is the development of graft-versus-host disease (GVHD) (Copelan. 2006. N Engl J Med. 354: 1813-1826 and Blazar and Murphy. 2005. Philos Trans R Soc Lond B Biol Sci. 360: 1747-1767). Alloreactive donor T cells are critical for causing GVHD (Fowler. 2006. Crit Rev Oncol Hematol. 57: 225-244 and Ferrara and Reddy. 2006. Semin Hematol. 43: 3-10), whereas recent data demonstrated a significant role for the naturally occurring thymic-derived donor CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) (Bluestone and Abbas. 2003. Nat Rev Immunol. 3: 253-257 and Shevach. 2006. Immunity. 25: 195-201) in suppressing experimental GVHD after bone marrow transplantation (Blazar and Taylor. 2005. Biol Blood Marrow Transpl. 11: 46-49 and Joffe and van Meerwijk. 2006. Semin Immunol. 18: 128-135) . Host APCs are required for induction of GVHD by the conventional donor T cells. However, it is not known whether they are also obligatory for donor Treg-mediated suppression of GVHD. Using multiple clinically relevant MHC-matched and -mismatched murine models of GVHD, we investigated the role of host APCs in the suppression of GVHD by donor Tregs. We found that alloantigen expression by the host APCs is necessary and sufficient for induction of GVHD protection by donor Tregs. This requirement was independent of their effect on the maintenance of Treg numbers and the production of IL-10 or IDO by the host APCs.
authors.affiliation: Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109, USA.
authors.forename: Isao
authors.initials: I
authors.lastname: Tawara
authors.forename: Warren D
authors.initials: WD
authors.lastname: Shlomchik
authors.forename: Angela
authors.initials: A
authors.lastname: Jones
authors.forename: Weiping
authors.initials: W
authors.lastname: Zou
authors.forename: Evelyn
authors.initials: E
authors.lastname: Nieves
authors.forename: Chen
authors.initials: C
authors.lastname: Liu
authors.forename: Tomomi
authors.initials: T
authors.lastname: Toubai
authors.forename: Raimon
authors.initials: R
authors.lastname: Duran-Struuck
authors.forename: Yaping
authors.initials: Y
authors.lastname: Sun
authors.forename: Shawn G
authors.initials: SG
authors.lastname: Clouthier
authors.forename: Rebecca
authors.initials: R
authors.lastname: Evers
authors.forename: Kathleen P
authors.initials: KP
authors.lastname: Lowler
authors.forename: Robert B
authors.initials: RB
authors.lastname: Levy
authors.forename: Pavan
authors.initials: P
authors.lastname: Reddy
mesh_terms: D000818:Animals; D017951:Antigen Presentation / Q000276:immunology; D000938:Antigen-Presenting Cells / Q000276:immunology* / Q000378:metabolism; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000276:immunology; D002469:Cell Separation; D004195:Disease Models, Animal; D005434:Flow Cytometry; D006086:Graft vs Host Disease / Q000276:immunology*; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D053645:Interleukin-2 Receptor alpha Subunit / Q000276:immunology / Q000378:metabolism; D008213:Lymphocyte Activation / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D016176:T-Lymphocyte Subsets / Q000276:immunology* / Q000378:metabolism; D050378:T-Lymphocytes, Regulatory / Q000276:immunology* / Q000378:metabolism
chemical_list: D000949:Histocompatibility Antigens Class II; D053645:Interleukin-2 Receptor alpha Subunit
references.citation: Biol Blood Marrow Transplant. 2002;8(10):525-35
references.pmid: 12434947
references.citation: J Clin Invest. 2002 May;109(10):1335-44
references.pmid: 12021249
references.citation: Bone Marrow Transplant. 2010 Jan;45(1):1-11
references.pmid: 19946340
references.citation: Nat Immunol. 2006 Jan;7(1):83-92
references.pmid: 16311599
references.citation: Methods. 2003 Oct;31(2):172-9
references.pmid: 12957575
references.citation: J Exp Med. 2001 Jun 4;193(11):1311-8
references.pmid: 11390438
references.citation: J Exp Med. 1982 Dec 1;156(6):1665-76
references.pmid: 6217272
references.citation: Nat Rev Immunol. 2007 May;7(5):340-52
references.pmid: 17438575
references.citation: J Clin Invest. 2004 Jul;114(2):280-90
references.pmid: 15254595
references.citation: J Exp Med. 2002 Aug 5;196(3):389-99
references.pmid: 12163567
references.citation: Nat Rev Immunol. 2004 Oct;4(10):762-74
references.pmid: 15459668
references.citation: Immunol Rev. 2006 Aug;212:74-85
references.pmid: 16903907
references.citation: Nat Rev Immunol. 2003 Mar;3(3):253-7
references.pmid: 12658273
references.citation: Blood. 2002 May 15;99(10):3493-9
references.pmid: 11986199
references.citation: Immunity. 2006 Jul;25(1):129-41
references.pmid: 16860762
references.citation: Blood. 2008 Mar 15;111(6):3257-65
references.pmid: 18077788
references.citation: Nature. 1981 Sep 10-16;293(5828):150-1
references.pmid: 7022229
references.citation: Nat Immunol. 2005 Apr;6(4):331-7
references.pmid: 15785758
references.citation: Immunity. 2006 Aug;25(2):195-201
references.pmid: 16920638
references.citation: J Immunol. 2006 Jun 1;176(11):6503-11
references.pmid: 16709807
references.citation: Blood. 2008 Apr 1;111(7):3884-92
references.pmid: 18223170
references.citation: Transplantation. 1981 Oct;32(4):321-5
references.pmid: 6460354
references.citation: Br J Haematol. 2004 May;125(4):455-62
references.pmid: 15142115
references.citation: Semin Immunol. 2006 Apr;18(2):128-35
references.pmid: 16458534
references.citation: Nat Med. 1999 Nov;5(11):1249-55
references.pmid: 10545990
references.citation: Nat Immunol. 2005 Apr;6(4):345-52
references.pmid: 15785760
references.citation: Immunity. 2009 May;30(5):656-65
references.pmid: 19464988
references.citation: Transplantation. 1985 Feb;39(2):162-8
references.pmid: 3155879
references.citation: Biol Blood Marrow Transplant. 2008 Jan;14(1 Suppl 1):129-35
references.pmid: 18162233
references.citation: J Clin Invest. 2008 Jul;118(7):2562-73
references.pmid: 18568076
references.citation: Transplantation. 1981 Sep;32(3):203-9
references.pmid: 6456580
references.citation: Immunity. 2009 Mar 20;30(3):458-69
references.pmid: 19303390
references.citation: J Exp Med. 1978 Dec 1;148(6):1687-98
references.pmid: 363972
references.citation: Blood. 2003 Jul 15;102(2):429-35
references.pmid: 12663438
references.citation: Nature. 1981 Sep 10-16;293(5828):149-50
references.pmid: 7022228
references.citation: Semin Hematol. 2006 Jan;43(1):3-10
references.pmid: 16412784
references.citation: Biol Blood Marrow Transplant. 2003 Apr;9(4):243-56
references.pmid: 12720217
references.citation: Science. 1999 Jul 16;285(5426):412-5
references.pmid: 10411505
references.citation: Blood. 2002 Sep 1;100(5):1903-9
references.pmid: 12176915
references.citation: Semin Immunol. 2006 Apr;18(2):103-10
references.pmid: 16458533
references.citation: Annu Rev Immunol. 2004;22:765-87
references.pmid: 15032596
references.citation: Nature. 1996 Sep 5;383(6595):81-5
references.pmid: 8779719
references.citation: J Exp Med. 2002 Aug 5;196(3):401-6
references.pmid: 12163568
references.citation: J Clin Invest. 2004 Nov;114(9):1198-208
references.pmid: 15520848
references.citation: Nat Med. 2002 Jun;8(6):575-81
references.pmid: 12042807
references.citation: Nat Med. 2005 Nov;11(11):1244-9
references.pmid: 16227991
references.citation: Philos Trans R Soc Lond B Biol Sci. 2005 Sep 29;360(1461):1747-67
references.pmid: 16147539